Authors
Loading...
Preclinical study demonstrates reduced inflammatory cytokines in mice using anti-CD3 nanoparticle microneedle patches, indicating potential for minimally invasive transdermal immunotherapy.
Choi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: